Chen‐Ying Liu

3.9k total citations · 1 hit paper
56 papers, 3.0k citations indexed

About

Chen‐Ying Liu is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Chen‐Ying Liu has authored 56 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 22 papers in Cell Biology and 13 papers in Oncology. Recurrent topics in Chen‐Ying Liu's work include Hippo pathway signaling and YAP/TAZ (19 papers), Wnt/β-catenin signaling in development and cancer (7 papers) and Ubiquitin and proteasome pathways (6 papers). Chen‐Ying Liu is often cited by papers focused on Hippo pathway signaling and YAP/TAZ (19 papers), Wnt/β-catenin signaling in development and cancer (7 papers) and Ubiquitin and proteasome pathways (6 papers). Chen‐Ying Liu collaborates with scholars based in China, United States and Singapore. Chen‐Ying Liu's co-authors include Qun‐Ying Lei, Kun‐Liang Guan, Bin Zhao, Yue Xiong, Long Cui, Zhengyu Zha, Shimin Zhao, Q. Richard Lu, Li Li and Wei Huang and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Genes & Development.

In The Last Decade

Chen‐Ying Liu

55 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein

2011 543 citations Bin Zhao, Chen‐Ying Liu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chen‐Ying Liu China	26	1.8k	1.8k	498	361	170	56	3.0k
Chunling Yi United States	19	1.4k 0.8×	1.1k 0.6×	526 1.1×	211 0.6×	138 0.8×	23	2.3k
Julien Fitamant United States	14	1.7k 0.9×	989 0.6×	648 1.3×	468 1.3×	463 2.7×	17	2.8k
Wannian Yang United States	28	1.6k 0.9×	730 0.4×	346 0.7×	236 0.7×	225 1.3×	54	2.1k
Olivier E. Pardo United Kingdom	24	1.9k 1.0×	561 0.3×	546 1.1×	552 1.5×	152 0.9×	47	2.5k
G B Mills United States	17	1.4k 0.8×	1.2k 0.7×	367 0.7×	249 0.7×	80 0.5×	19	2.5k
Qiong Lin China	23	1.4k 0.8×	459 0.3×	287 0.6×	227 0.6×	212 1.2×	59	1.8k
Michael DeRan United States	12	899 0.5×	800 0.4×	212 0.4×	150 0.4×	54 0.3×	13	1.5k
Imelda Mercado‐Uribe United States	24	1.2k 0.7×	421 0.2×	922 1.9×	756 2.1×	111 0.7×	28	2.2k
Roy Katso United Kingdom	13	1.9k 1.0×	466 0.3×	409 0.8×	206 0.6×	131 0.8×	15	2.6k
Anthony Polverino United States	18	2.3k 1.3×	463 0.3×	697 1.4×	240 0.7×	69 0.4×	29	2.8k

Countries citing papers authored by Chen‐Ying Liu

Since Specialization

Citations

This map shows the geographic impact of Chen‐Ying Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen‐Ying Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen‐Ying Liu more than expected).

Fields of papers citing papers by Chen‐Ying Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chen‐Ying Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen‐Ying Liu. The network helps show where Chen‐Ying Liu may publish in the future.

Co-authorship network of co-authors of Chen‐Ying Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Chen‐Ying Liu. A scholar is included among the top collaborators of Chen‐Ying Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chen‐Ying Liu. Chen‐Ying Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhu, Zhehui, Rui Ding, Wei Yu, et al.. (2025). YAP/TEAD4/SP1-induced VISTA expression as a tumor cell-intrinsic mechanism of immunosuppression in colorectal cancer. Cell Death and Differentiation. 32(5). 911–925. 3 indexed citations

Xu, Weimin, Wenbo Tang, Wensong Ge, et al.. (2025). Redox‐Induced Stabilization of AMBRA1 by USP7 Promotes Intestinal Oxidative Stress and Colitis Through Antagonizing DUB3‐Mediated NRF2 Deubiquitination. Advanced Science. 12(12). e2411320–e2411320. 1 indexed citations

Tang, Wenbo, Yi‐Qing Yang, Weimin Xu, et al.. (2024). The RNA helicase DDX21 activates YAP to promote tumorigenesis and is transcriptionally upregulated by β-catenin in colorectal cancer. Oncogene. 43(44). 3227–3239. 1 indexed citations

Li, Lingling, Dongxian Jiang, Qiao Zhang, et al.. (2024). Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression. Cancer Research. 84(17). 2888–2910. 3 indexed citations

Wang, Xuefei, Yuegui Guo, Jie Zhong, et al.. (2024). Computer-aided molecular design and optimization of potent inhibitors disrupting APC‒Asef interaction. Acta Pharmaceutica Sinica B. 14(6). 2631–2645. 4 indexed citations

Wang, Chao, Zhen Wu, Changchun Wang, et al.. (2024). Aspirin‐Mediated Acetylation of SIRT1 Maintains Intestinal Immune Homeostasis. Advanced Science. 11(19). e2306378–e2306378. 5 indexed citations

Xu, Weimin, Yaosheng Wang, Wenbo Tang, et al.. (2024). AMBRA1 promotes intestinal inflammation by antagonizing PP4R1/PP4c mediated IKK dephosphorylation in an autophagy-independent manner. Cell Death and Differentiation. 31(5). 618–634. 6 indexed citations

Bao, Weilian, Yan You, Jiahui Ni, et al.. (2023). Inhibiting sorting nexin 10 promotes mucosal healing through SREBP2-mediated stemness restoration of intestinal stem cells. Science Advances. 9(35). eadh5016–eadh5016. 15 indexed citations

Song, Jinglue, Xia Shen, Yun Liu, et al.. (2023). The YAP–TEAD4 complex promotes tumor lymphangiogenesis by transcriptionally upregulating CCBE1 in colorectal cancer. Journal of Biological Chemistry. 299(4). 103012–103012. 12 indexed citations

10.

Qian, Xiaolong, Yaqing Li, Chen‐Ying Liu, et al.. (2023). Effects of tumor-infiltrating lymphocytes on nonresponse rate of neoadjuvant chemotherapy in patients with invasive breast cancer. Scientific Reports. 13(1). 9256–9256. 4 indexed citations

11.

Zhong, Jie, Yuegui Guo, Shaoyong Lu, et al.. (2022). Rational design of a sensitivity-enhanced tracer for discovering efficient APC–Asef inhibitors. Nature Communications. 13(1). 4961–4961. 10 indexed citations

12.

Liu, Fangyuan, Weijun Ou, Wenbo Tang, et al.. (2021). Increased AOC1 Expression Promotes Cancer Progression in Colorectal Cancer. Frontiers in Oncology. 11. 657210–657210. 21 indexed citations

13.

Gu, Chang, Zhenyu Huang, Chen‐Ying Liu, et al.. (2020). TEAD4 promotes tumor development in patients with lung adenocarcinoma via ERK signaling pathway. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1866(12). 165921–165921. 45 indexed citations

14.

Wang, Yuhan, Zhehui Zhu, Zhenyu Huang, et al.. (2020). Bromodomain and Extraterminal (BET) protein inhibition suppresses tumor progression and inhibits HGF-MET signaling through targeting cancer-associated fibroblasts in colorectal cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1866(12). 165923–165923. 7 indexed citations

15.

Wu, Tingyu, Guanghui Wang, Wei Chen, et al.. (2018). Co-inhibition of BET proteins and NF-κB as a potential therapy for colorectal cancer through synergistic inhibiting MYC and FOXM1 expressions. Cell Death and Disease. 9(3). 315–315. 35 indexed citations

16.

Liu, Chen‐Ying, et al.. (2017). ETS (E26 transformation-specific) up-regulation of the transcriptional co-activator TAZ promotes cell migration and metastasis in prostate cancer. Journal of Biological Chemistry. 292(22). 9420–9430. 43 indexed citations

17.

Wu, Tingyu, Wei Chen, Yongwang Zhong, et al.. (2016). Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor. Molecular Cancer Therapeutics. 16(4). 717–728. 17 indexed citations

18.

Liu, Chen‐Ying, Zhengyu Zha, Xin Zhou, et al.. (2010). The Hippo Tumor Pathway Promotes TAZ Degradation by Phosphorylating a Phosphodegron and Recruiting the SCFβ-TrCP E3 Ligase. Journal of Biological Chemistry. 285(48). 37159–37169. 435 indexed citations

19.

Liu, Chen‐Ying, Tingting Li, Yanping Xu, et al.. (2010). PP1 Cooperates with ASPP2 to Dephosphorylate and Activate TAZ. Journal of Biological Chemistry. 286(7). 5558–5566. 111 indexed citations

20.

Zhang, Heng, Chen‐Ying Liu, Zhengyu Zha, et al.. (2009). TEAD Transcription Factors Mediate the Function of TAZ in Cell Growth and Epithelial-Mesenchymal Transition. Journal of Biological Chemistry. 284(20). 13355–13362. 459 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact